Benitec Biopharma INC. (BNTC) — SC 13D/A Filings

All SC 13D/A filings from Benitec Biopharma INC.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (2)

Suvretta Capital Management Files 13D/A for Benitec Biopharma — Nov 18, 2024 Risk: medium
On November 18, 2024, Suvretta Capital Management, LLC filed an amendment (Amendment #2) to its Schedule 13D for Benitec Biopharma Inc. The filing indicates a c
Suvretta Capital Amends Benitec Biopharma Stake — Sep 30, 2024 Risk: medium
Suvretta Capital Management, LLC, through Averill Madison Master Fund, Ltd. and Averill Master Fund, Ltd., has amended its Schedule 13D filing regarding Benitec

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX